Optimizing criteria for N-terminal pro-B-type natriuretic peptide for eligibility and enrichment in trials in heart failure with preserved, mid-range and reduced ejection fraction

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure - Other Chronic Heart Failure, Other HFA Premium Access Heart Failure 2018

About the speaker

Photo

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Professor C. Chavez-Mendez (Mexico City, MX)
Presentation thumbnail
Associate Professor S. Cho (Goyang, KR)
Presentation thumbnail
Professor M. Rivera Rodriguez (Mexico, MX)
Presentation thumbnail
Mr N. Marcks (Maastricht, NL)
Presentation thumbnail
Doctor D. Bodez (Creteil, FR)

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET

ESC 365 is supported by

ESC 365 is supported by